Novo Nordisk apologizes for not disclosing sponsorship of anti-obesity training

The chief executive of pharma group Novo Nordisk has apologised for breaking the UK industry code by failing to disclose its sponsorship of obesity and weight management training courses for healthcare professionals that also promoted its weight loss drug.